Uniphar

H1 results reflect sharp acceleration in EPS growth

  • Sectors : Pharma and healthcare
  • Companies : Uniphar

Ratings and price correct at time of issue.

  • Uniphar

    Closing Price: 405c

  • RATING 27/08/19

  • PREVIOUS RATING N/A

DAVY VIEW

Uniphar grew its EPS by 21% in H1 2025. This is the company’s fastest rate of growth in several years and is driven by organic gross profit growth, accretion from its share buyback and the benefit of declining yield curves on the finance charge. All targets have been reiterated, and the outlook is very positive.

Download full report with analyst certification and important disclosures

Sep 2 2025, 07:10 IST/BST

Download